Immune cell-derived small extracellular vesicles in cancer treatment

키워드

참고문헌 (73)

1. Thery C, "Minimal information for studies of extracellular vesicles 2018(MISEV 2018) : a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines", J Extracell Vesicles, 7, pp.1535750~ (2018)
2. Kalluri R, "The biology, function, and biomedical applications of exosomes", Science, 367, pp.eaau6977~ (2020)
3. Thery C, "Exosomes : composition, biogenesis and function", Nat Rev Immunol, 2, pp.569~579 (2002)
4. Kahlert C, "Exosomes in tumor microenvironment influence cancer progression and metastasis", J Mol Med(Berl), 91, pp.431~437 (2013)
5. Mathieu M, "Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication", Nat Cell Biol, 21, pp.9~17 (2019)
6. Bebelman MP, "Biogenesis and function of extracellular vesicles in cancer", Pharmacol Ther, 188, pp.1~11 (2018)
7. Ciardiello C, "Focus on extracellular vesicles : new frontiers of cell-to-cell communication in cancer", Int J Mol Sci, 17, pp.175~ (2016)
8. van Niel G, "Shedding light on the cell biology of extracellular vesicles", Nat Rev Mol Cell Biol, 19, pp.213~228 (2018)
9. Urbanelli L, "Signaling pathways in exosomes biogenesis, secretion and fate", Genes(Basel), 4, pp.152~170 (2013)
10. McLellan AD, "Exosome release by primary B cells", Crit Rev Immunol, 29, pp.203~217 (2009)
11. Segura E, "Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses", Blood Cells Mol Dis, 35, pp.89~93 (2005)
12. Paolillo M, "Integrins and exosomes, a dangerous liaison in cancer progression", Cancers (Basel), 9 (2017)
13. Segura E, "CD8+ dendritic cells use LFA-1 to capture MHCpeptide complexes from exosomes in vivo", J Immunol, 179, pp.1489~1496 (2007)
14. Kalluri R, "The biology and function of exosomes in cancer", J Clin Invest, 126, pp.1208~1215 (2016)
15. Gao D, "Exosomes in cancer therapy : a novel experimental strategy", Am J Cancer Res, 8, pp.2165~2175 (2018)
16. Batrakova EV, "Using exosomes, naturally-equipped nanocarriers, for drug delivery", J Control Release, 219, pp.396~405 (2015)
17. Kibria G, "Exosomes as a drug delivery system in cancer therapy : potential and challenges", Mol Pharm, 15, pp.3625~3633 (2018)
18. Yong T, "Tumor exosomebased nanoparticles are efficient drug carriers for chemotherapy", Nat Commun, 10, pp.3838~ (2019)
19. Li Y, "Immune cell metabolism in tumor microenvironment", Adv Exp Med Biol, 1011, pp.163~196 (2017)
20. Guo S, "Effect of stromal cells in tumor microenvironment on metastasis initiation", Int J Biol Sci, 14, pp.2083~2093 (2018)
21. Steinman RM, "Decisions about dendritic cells : past, present, and future", Annu Rev Immunol, 30, pp.1~22 (2012)
22. Pitt JM, "Dendritic cellderived exosomes as immunotherapies in the fight against cancer", J Immunol, 193, pp.1006~1011 (2014)
23. Chen DS, "Oncology meets immunology : the cancer-immunity cycle", Immunity, 39, pp.1~10 (2013)
24. Saxena M, "Therapeutic cancer vaccines", Nat Rev Cancer, 21, pp.360~378 (2021)
25. Santos P, "Exosome-based vaccines : history, current state, and clinical trials", Front Immunol, 12, pp.711565~ (2021)
26. Zitvogel L, "Eradication of established murine tumors using a novel cell-free vaccine : dendritic cell-derived exosomes", Nat Med, 4, pp.594~600 (1998)
27. Andre F, "Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cellderived exosomes transfer functional MHC class I", peptide complexes to dendritic cells, 2004, pp.172, 2126~2136
28. Pitt JM, "Dendritic cell-derived exosomes for cancer therapy", J Clin Invest, 126, pp.1224~1232 (2016)
29. Matsumoto K, "Exosomes secreted from monocyte-derived dendritic cells support in vitro naive CD4+ T cell survival through NF-(kappa)B activation", Cell Immunol, 231, pp.20~29 (2004)
30. Qazi KR, "Antigen-loaded exosomes alone induce Th1-type memory through a B-cell-dependent mechanism", Blood, 113, pp.2673~2683 (2009)
31. Segura E, "ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming", Blood, 106, pp.216~223 (2005)
32. Naslund TI, "Dendritic cell-derived exosomes need to activate both T and B cells to induce antitumor immunity", J Immunol, 190, pp.2712~2719 (2013)
33. Wei G, "Dendritic cells derived exosomes migration to spleen and induction of inflammation are regulated by CCR7", Sci Rep, 7, pp.42996~ (2017)
34. Nolte-’t Hoen EN, "Activated T cells recruit exosomes secreted by dendritic cells via LFA-1", Blood, 113, pp.1977~1981 (2009)
35. Thery C, "Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes", Nat Immunol, 3, pp.1156~1162 (2002)
36. Romagnoli GG, "Dendritic cell-derived exosomes may be a tool for cancer immunotherapy by converting tumor cells into immunogenic targets", Front Immunol, 5, pp.692~ (2014)
37. Guan S, "Umbilical cord blood-derived dendritic cells loaded with BGC823tumor antigens and DC-derived exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumor immunity in vitro and in vivo", Cent Eur J Immunol, 39, pp.142~151 (2014)
38. Lu Z, "Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models", J Hepatol, 67, pp.739~748 (2017)
39. Viaud S, "Dendritic cellderived exosomes promote natural killer cell activation and proliferation : a role for NKG2D ligands and IL-15Ralpha", PLoS One, 4, pp.e4942~ (2009)
40. Besse B, "Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC", Oncoimmunology, 5, pp.e1071008~ (2016)
41. Munich S, "Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands", Oncoimmunology, 1, pp.1074~1083 (2012)
42. Sobo-Vujanovic A, "Dendritic-cell exosomes cross-present Toll-like receptor-ligands and activate bystander dendritic cells", Cell Immunol, 289, pp.119~127 (2014)
43. Simhadri VR, "Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function", PLoS One, 3, pp.e3377~ (2008)
44. Wang J, "Effect of hyperthermic CO2-treated dendritic cell-derived exosomes on the human gastric cancer AGS cell line", Oncol Lett, 10, pp.71~76 (2015)
45. Guo F, "Anti-tumour effects of exosomes in combination with cyclophosphamide and polyinosinic-polycytidylic acid", J Int Med Res, 36, pp.1342~1353 (2008)
46. Wahlgren J, "Activated human T cells secrete exosomes that participate in IL-2 mediated immune response signaling", PLoS One, 7, pp.e49723~ (2012)
47. Min H, "Exosomes derived from irradiated esophageal carcinoma-infiltrating T cells promote metastasis by inducing the epithelial-mesenchymal transition in esophageal cancer cells", Pathol Oncol Res, 24, pp.11~18 (2018)
48. Fu W, "CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity", Nat Commun, 10, pp.4355~ (2019)
49. Zhang H, "CD4(+)T cell-released exosomes inhibit CD8(+)cytotoxic T-lymphocyte responses and antitumor immunity", Cell Mol Immunol, 8, pp.23~30 (2011)
50. Lu J, "CD4(+)T cell-released extracellular vesicles potentiate the efficacy of the HBsAg vaccine by enhancing B cell responses", Adv Sci(Weinh), 6, pp.1802219~ (2019)
51. Peters PJ, "Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes", J Exp Med, 173, pp.1099~1109 (1991)
52. Li L, "IL-12stimulates CTLs to secrete exosomes capable of activating bystander CD8(+)T cells", Sci Rep, 7, pp.13365~ (2017)
53. Seo N, "Activated CD8(+)T cell extracellular vesicles prevent tumour progression by targeting of lesional mesenchymal cells", Nat Commun, 9, pp.435~ (2018)
54. Cai Z, "Activated T cell exosomes promote tumor invasion via Fas signaling pathway", J Immunol, 188, pp.5954~5961 (2012)
55. Xie Y, "Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide", MHC class I and Fas ligand-mediated cytotoxicity, 2010, pp.185, 5268~5278
56. Lugini L, "Immune surveillance properties of human NK cell-derived exosomes", J Immunol, 189, pp.2833~2842 (2012)
57. Jong AY, "Large-scale isolation and cytotoxicity of extracellular vesicles derived from activated human natural killer cells", J Extracell Vesicles, 6, pp.1294368~ (2017)
58. Zhu L, "Exosomes derived from natural killer cells exert therapeutic effect in melanoma", Theranostics, 7, pp.2732~2745 (2017)
59. Neviani P, "Natural killer-derived exosomal miR-186 inhibits neuroblastoma growth and immune escape mechanisms", Cancer Res, 79, pp.1151~1164 (2019)
60. Zhu L, "Enhancement of antitumor potency of extracellular vesicles derived from natural killer cells by IL-15 priming", Biomaterials, 190-191, pp.38~50 (2019)
61. Ngambenjawong C, "Progress in tumor-associated macrophage(TAM)-targeted therapeutics", Adv Drug Deliv Rev, 114, pp.206~221 (2017)
62. Bernsmeier C, "Innate immune cells in cirrhosis", J Hepatol, 73, pp.186~201 (2020)
63. Cheng L, "Exosomes from M1-polarized macrophages potentiate the cancer vaccine by creating a pro-inflammatory microenvironment in the lymph node", Mol Ther, 25, pp.1665~1675 (2017)
64. Wang P, "Exosomes from M1-polarized macrophages enhance paclitaxel antitumor activity by activating macrophages-mediated inflammation", Theranostics, 9, pp.1714~1727 (2019)
65. Li Z, "Exosomal miRNA-16-5p derived from M1 macrophages enhances T cell-dependent immune response by regulating PD-L1 in gastric cancer", Front Cell Dev Biol, 8, pp.572689~ (2020)
66. Lin Y, "Tumor-associated macrophages in tumor metastasis : biological roles and clinical therapeutic applications", J Hematol Oncol, 12, pp.76~ (2019)
67. Wu XQ, "Emerging role of microRNAs in regulating macrophage activation and polarization in immune response and inflammation", Immunology, 148, pp.237~248 (2016)
68. Choo YW, "M1 macrophagederived nanovesicles potentiate the anticancer efficacy of immune checkpoint inhibitors", ACS Nano, 12, pp.8977~8993 (2018)
69. Derakhshani A, "Mast cells : a double-edged sword in cancer", Immunol Lett, 209, pp.28~35 (2019)
70. Farcas M, "Natural killer cellderived extracellular vesicles in cancer therapy", Scand J Immunol, 92, pp.e12938~ (2020)
71. Busatto S, "Tangential flow filtration for highly efficient concentration of extracellular vesicles from large volumes of fluid", Cells, 7, pp.273~ (2018)
72. Escudier B, "Vaccination of metastatic melanoma patients with autologous dendritic cell(DC)derived-exosomes : results of thefirst phase I clinical trial", J Transl Med, 3, pp.10~ (2005)
73. Morse MA, "A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer", J Transl Med, 3, pp.9~ (2005)

관련 논문AI추천